Comprehensive proteogenomic characterization reveals clinically relevant molecular subtypes associated with medulloblastoma progression - PubMed
4 hours ago
- #Proteogenomics
- #Molecular Subtypes
- #Medulloblastoma
- Study performs integrated multi-omics to refine medulloblastoma molecular classification.
- Identifies seven subtypes: SHHα, SHHβ, G4α, G4β, G4γ, plus others.
- SHHβ and G4γ subtypes show neuronal differentiation linked to better outcomes.
- Proteomic/kinomic vulnerabilities found in poor-outcome subtypes.
- Suggests targeted therapies (e.g., CDK1/2, PARP, proteasome inhibitors).
- Proposes using proteomic signatures to guide patient-specific treatments.